Sawai’s Upsher-Smith Takes Aim At US Corticotropin Opportunity
Collaboration With Peptide Specialist AmbioPharm
Executive Summary
Upsher-Smith Laboratories, the US arm of Japan’s Sawai Pharmaceutical, has another challenging project in the pipeline with an agreement to develop and market a follow-on version of Mallinckrodt’s Acthar Gel (corticotropin). The Japanese firm revealed Upsher-Smith’s latest finances as it revealed first-quarter financial results.